Updates
Jubilant receives ANDA approval for Bupropion Hydrochloride Extended-Release Tablets06-07-2017
Updates
Jubilant receives ANDA approval for Bupropion Hydrochloride Extended-Release TabletsUpdates
Schedule of Investor Conference Call for Jubilant Life Sciences Limited - Unaudited Financial Results for the quarter ended June 30, 2017 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call on July 18, 2017 after submission of the financial results for the quarter ended June 30,...Board Meeting On July 18, 2017
In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations'), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, July 18, 2017, to inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2017.Jubilant Life ties up with Dutch firm Barentz for food & nutrition market
Through this collaboration Jubilant plans to offer nutrient premixes & blends to its customersUpdates
Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for Designated Persons' from Saturday, June 24, 2017 and the same shall remain closed till 48 hours after the announcement of the financial results for the quarter ending June 30, 2017 to the Stock Exchanges....Pharma stocks in green; Jubilant Life surges
Pharma stocks have been showing a volatile trend in the recent times and have remained mostly stock-specific.Updates
With reference to the earlier letter dated May 09, 2017, Jubilant Life Sciences Ltd has now informed BSE that the National Green Tribunal (NGT) has passed an oral order dated May 31, 2017 allowing restart of the manufacturing operations of Company's Distillery unit at Gajraula from June 01, 2017 subject to certain stipulations. Pursuant to the said order, the Company have restarted operations of the Distillery unit with effect from June 01, 2017....Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jubilant Stock Holding Pvt Ltd